| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/13/2001 | US6200801 A polycation and a binding moiety of defined amino acid sequence capable of binding to a serpin enzyme complex receptor for targeted gene delivery; gene therapy; antisense agents |
| 03/13/2001 | US6200795 Polypeptides having uroporphyrinogen decarboxylase activity and nucleic acids encoding same |
| 03/13/2001 | US6200787 Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae |
| 03/13/2001 | US6200780 Human interferon-ε(IFN-ε), a type I interferon |
| 03/13/2001 | US6200779 Nucleotide sequences which code protein associated with bacterial infection; for prevent of infections and associated defects |
| 03/13/2001 | US6200778 Genomic sequences for protein production and delivery |
| 03/13/2001 | US6200777 Human p101 polynucleotides |
| 03/13/2001 | US6200776 Polynucleotides encoding human sodium bicarbonate cotransporters |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200774 Compounds |
| 03/13/2001 | US6200770 Protein kinase molecules and uses therefor |
| 03/13/2001 | US6200768 Detecting compounds efficient in the dissolution of an alzheimer's protein; incubate preferential protein with kinase, monitor helix formation, incubate with modulator and detect blocking action by modulator |
| 03/13/2001 | US6200606 Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
| 03/13/2001 | US6200560 Adeno-associated virus vectors for expression of factor VIII by target cells |
| 03/08/2001 | WO2001016365A1 Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids |
| 03/08/2001 | WO2001016362A2 Fatty acid desaturase gene from plants |
| 03/08/2001 | WO2001016345A2 Sequence-specific dna recombination in eukaryotic cells |
| 03/08/2001 | WO2001016344A1 Modified adenoviral fibre and uses thereof |
| 03/08/2001 | WO2001016342A1 Use of lentiviral vectors for antigen presentation in dendritic cells |
| 03/08/2001 | WO2001016340A1 Flax seed specific promoters |
| 03/08/2001 | WO2001016322A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016318A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | WO2001016317A2 Polycyclic aromatic hydrocarbon induced molecules |
| 03/08/2001 | WO2001016315A1 sIGH AFFINITY CHOLINE TRANSPORTER |
| 03/08/2001 | WO2001016314A1 Iren protein, its preparation and use |
| 03/08/2001 | WO2001016312A2 Nucleic acid based modulators of gene expression |
| 03/08/2001 | WO2001016308A2 Plant sterol acyltransferases |
| 03/08/2001 | WO2001016304A2 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 03/08/2001 | WO2001016303A2 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis |
| 03/08/2001 | WO2001016301A1 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 03/08/2001 | WO2001016297A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | WO2001016296A2 Use of cytokines, cells, and mitogens to inhibit graft versus host disease |
| 03/08/2001 | WO2001016295A1 Novel natriuretic peptide receptors, interacting compounds and methods of regulating proliferation and/or survival of neurons |
| 03/08/2001 | WO2001016294A2 Metal binding compounds and their use in cell culture medium compositions |
| 03/08/2001 | WO2001016293A2 Dna encoding the human serine protease t |
| 03/08/2001 | WO2001016292A2 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | WO2001016290A2 Dna encoding the human serine protease eos |
| 03/08/2001 | WO2001016289A2 Zymogen activation system |
| 03/08/2001 | WO2001016288A2 Dna encoding the human serine protease c-e |
| 03/08/2001 | WO2001016286A2 A tryptamine treated, human differentiated, neuronal alzheimer-like cell and attendant methods of cell modeling |
| 03/08/2001 | WO2001016183A1 Monoclonal antibodies and vaccines against epitopes on the ebola virus glycoprotein |
| 03/08/2001 | WO2001016176A2 Transgenic animal model for neurodegenerative diseases |
| 03/08/2001 | WO2001016171A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016165A2 Apoptin-associating protein |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016155A1 Antibodies specific for fullerenes |
| 03/08/2001 | WO2001015755A2 Methods and compositions for delivery of pharmaceutical agents |
| 03/08/2001 | WO2001015753A1 New humanized biomaterials, a process for their preparation and their applications |
| 03/08/2001 | WO2001015740A1 Single-stranded oligodeoxynucleotide mutational vectors |
| 03/08/2001 | WO2001015736A2 Interferon-beta conjugates |
| 03/08/2001 | WO2001015722A2 Methods useful in affecting apoptosis |
| 03/08/2001 | WO2001015676A2 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | WO2001015520A1 Pa28 modified transgenic mice |
| 03/08/2001 | WO2000068396A3 Bacillus circulans xylanase mutants |
| 03/08/2001 | WO2000066735A3 Human ion channel proteins |
| 03/08/2001 | WO2000063425A3 Compound assay using nematodes |
| 03/08/2001 | WO2000061766A3 Telomerase-specific cancer vaccine |
| 03/08/2001 | WO2000061624A8 48 human secreted proteins |
| 03/08/2001 | WO2000058475A3 Streptococcus pneumoniae antigens |
| 03/08/2001 | WO2000057861A3 Use of cytidine derivatives for the treatment of leukaemia |
| 03/08/2001 | WO2000049137A3 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 03/08/2001 | WO2000039283A8 Use of cd40 engagement to alter t cell receptor usage |
| 03/08/2001 | WO2000026246A9 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 03/08/2001 | WO2000023588A8 G-protein coupled receptors |
| 03/08/2001 | WO2000020447A8 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 03/08/2001 | WO2000012736A9 A new method of identifying non-host plant disease resistance genes |
| 03/08/2001 | WO1999020723A8 Multiply-substituted protease variant and amylase variant-containing cleaning compositions |
| 03/08/2001 | DE19941609A1 Fettsäure-Desaturase-Gen aus Pflanzen Fatty acid desaturase gene from plants |
| 03/08/2001 | CA2533856A1 Exogenic allelism |
| 03/08/2001 | CA2403243A1 Nucleic acid based modulators of gene expression |
| 03/08/2001 | CA2392010A1 Use of lentiviral vectors for antigen presentation in dendritic cells |
| 03/08/2001 | CA2388734A1 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | CA2387291A1 Dna encoding the human serine protease t |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2384026A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | CA2383910A1 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 03/08/2001 | CA2383877A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | CA2383784A1 Apoptin-associating protein |
| 03/08/2001 | CA2383693A1 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2383606A1 Iren protein, its preparation and use |
| 03/08/2001 | CA2383601A1 Dna encoding the human serine protease eos |
| 03/08/2001 | CA2383564A1 Transgenic animal model for neurodegenerative diseases |
| 03/08/2001 | CA2383460A1 Metal binding compounds and their use in cell culture medium compositions |
| 03/08/2001 | CA2383015A1 Antibodies specific for fullerenes |
| 03/08/2001 | CA2382961A1 Zymogen activation system |
| 03/08/2001 | CA2382953A1 Dna encoding the human serine protease c-e |
| 03/08/2001 | CA2382845A1 Fatty acid desaturase gene from plants |
| 03/08/2001 | CA2382622A1 Polycyclic aromatic hydrocarbon induced molecules |
| 03/08/2001 | CA2382562A1 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | CA2382381A1 Pa28 modified transgenic mice |
| 03/08/2001 | CA2382120A1 Single-stranded oligodeoxynucleotide mutational vectors |
| 03/08/2001 | CA2382030A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | CA2381901A1 A plant lecithin:cholesterol acyltransferase-like polypeptide |
| 03/08/2001 | CA2381451A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | CA2380760A1 New interferon beta-like molecules |
| 03/08/2001 | CA2380355A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2378755A1 New humanized biomaterials, a process for their preparation and their applications |
| 03/08/2001 | CA2348158A1 Modified adenoviral fibre and uses thereof |